Klaus-Jürgen Walgenbach
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Klaus-Jürgen Walgenbach has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- M. Voigt
Department of Plastic and Hand Surgery, University of Freiburg Medical Center, Germany
5 shared publications - G. B. Stark
Department of Plastic and Hand Surgery, University of Freiburg Medical Centre, Albert-Ludwigs University, Hugstetter Str. 55, 79106 Freiburg, GermanyTel.: +49-761-270-2817, Fax: +49-761-270-2501
4 shared publications C Andree
3 shared publicationsE Tánczos
3 shared publications- R E Horch
Department of Plastic and Hand Surgery, Albert-Ludwigs-University Freiburg, Medical School, Germany
3 shared publications Christoph Andree
Department of Plastic and Hand Surgery, University of Freiburg, and Valley TEC (Valley Tissue Engineering Center), Freiburg, Germany
2 shared publications
Latest Publications
- 1 January 2002
- Published by Taylor & Francis in Journal of Investigative Surgery
- Vol. 15 (3) , 153-162
A Potential Role for Mast Cells in the of bFGF From Normal Myocytes During Angiogenesis In Vivo
Basic fibroblast growth factor (bFGF) is a potent angiogenic factor produced by cells of mesodermal and neuroectodermal origin. Despite numerous advances, the precise mechanism of bFGF release from cells still remains unknown. Upon release from cells, the protein is stored and protected in the extracellular matrix by binding to heparan sulfate proteoglycans. A number of reports suggest that degrading enzymes secreted by mast cells may play a role in the release of bFGF from connective tissue stores. Additionally, mast cells are believed to play a role in the formation of new blood vessels. In this report, we studied the events involved in neovascularization using a well-characterized model of angiogenesis in rabbits where neovascularization is induced by transfer of a well-perfused rectus abdominis muscle flap to an ischemic limb. Using this model, we demonstrate that bFGF expression is induced in normal myofibers and bFGF is released in the wound fluid at the ischemic/nonischemic interface. The highest concentrations of bFGF were detected on days 14 and 21 postoperation. We also show that the number of mast cells and their degranulation correlate with the release of bFGF from adjacent muscle tissue and the appearance of the growth factor in the wound fluid. There appears to exist a temporal correlation between number of mast cells, their degranulation, and the release of bFGF during angiogenesis in vivo.
- 1 January 2002
- Published by Taylor & Francis in Journal of Investigative Surgery
- Vol. 15 (3) , 153-162
A Potential Role for Mast Cells in the of bFGF From Normal Myocytes During Angiogenesis In Vivo
Basic fibroblast growth factor (bFGF) is a potent angiogenic factor produced by cells of mesodermal and neuroectodermal origin. Despite numerous advances, the precise mechanism of bFGF release from cells still remains unknown. Upon release from cells, the protein is stored and protected in the extracellular matrix by binding to heparan sulfate proteoglycans. A number of reports suggest that degrading enzymes secreted by mast cells may play a role in the release of bFGF from connective tissue stores. Additionally, mast cells are believed to play a role in the formation of new blood vessels. In this report, we studied the events involved in neovascularization using a well-characterized model of angiogenesis in rabbits where neovascularization is induced by transfer of a well-perfused rectus abdominis muscle flap to an ischemic limb. Using this model, we demonstrate that bFGF expression is induced in normal myofibers and bFGF is released in the wound fluid at the ischemic/nonischemic interface. The highest concentrations of bFGF were detected on days 14 and 21 postoperation. We also show that the number of mast cells and their degranulation correlate with the release of bFGF from adjacent muscle tissue and the appearance of the growth factor in the wound fluid. There appears to exist a temporal correlation between number of mast cells, their degranulation, and the release of bFGF during angiogenesis in vivo.
- Open Access
- 11 July 2001
- Published by Wiley in The Anatomical Record
- Vol. 263 (4) , 372-378
Tissue engineering in plastic reconstructive surgery
Tissue engineering (TE) is a new interdisciplinary field of applied research combining engineering and biosciences together with clinical application, mainly in surgical specialities, to develop living substitutes for tissues and organs. Tissue engineering approaches can be categorized into substitutive approaches, where the aim is the ex vivo construction of a living tissue or organ similar to a transplant, vs. histioconductive or histioinductive concepts in vivo. The main successful approaches in developing tissue substitutes to date have been progresses in the understanding of cell–cell interactions, the selection of appropriate matrices (cell–matrix interaction) and chemical signalling (cytokines, growth factors) for stimulation of cell proliferation and migration within a tissue‐engineered construct. So far virtually all mammalian cells can be cultured under specific culture conditions and in tissue specific matrices. Future progress in cell biology may permit the use of pluripotent stem cells for TE. The blueprint for tissue differentiation is the genome: for this it is reasonable to combine tissue engineering with gene therapy. The key to the progress of tissue engineering is an understanding between basic scientists, biochemical engineers, clinicians, and industry. Anat Rec 263:372–378, 2001.
- 11 July 2001
- Published by Wiley in The Anatomical Record
- Vol. 263 (4) , 372-378
Open AccessTissue engineering in plastic reconstructive surgery
Tissue engineering (TE) is a new interdisciplinary field of applied research combining engineering and biosciences together with clinical application, mainly in surgical specialities, to develop living substitutes for tissues and organs. Tissue engineering approaches can be categorized into substitutive approaches, where the aim is the ex vivo construction of a living tissue or organ similar to a transplant, vs. histioconductive or histioinductive concepts in vivo. The main successful approaches in developing tissue substitutes to date have been progresses in the understanding of cell–cell interactions, the selection of appropriate matrices (cell–matrix interaction) and chemical signalling (cytokines, growth factors) for stimulation of cell proliferation and migration within a tissue‐engineered construct. So far virtually all mammalian cells can be cultured under specific culture conditions and in tissue specific matrices. Future progress in cell biology may permit the use of pluripotent stem cells for TE. The blueprint for tissue differentiation is the genome: for this it is reasonable to combine tissue engineering with gene therapy. The key to the progress of tissue engineering is an understanding between basic scientists, biochemical engineers, clinicians, and industry. Anat Rec 263:372–378, 2001.
- 1 July 2001
- Published by Hogrefe Publishing Group in Vasa
- Vol. 30 (3) , 206-211
Management therapierefraktärer hypovaskularisierter Wunden durch freie Muskelverpflanzung
Background: Chronic ulceration as a complication of arteriosclerotic disease, venous congestion or diabetes mellitus is still a serious clinical problem, resulting in immobilization, extended hospitalization and cost-intensive treatment. Other than standard conservative treatment protocols or early amputation, microsurgical free transfer of well vascularized muscle tissue onto chronic wounds can induce angiogenesis and improve wound healing even in the hypovascularized wound. Patients: From 1993–1999 we treated 12 patients (mean age: 46 years) with vascular ulcers of the lower extremity with free muscle or fasciocutaneous tissue transfer. Results: The average hospitalization was 51.4 days. The perioperative mortality was zero. In one patient with factor V deficiency a partial flap necrosis occurred. Two revisions of the micro anastomoses had to be performed. Two seromas occurred at the donor site. No secondary flap loss was observed. Extremity or stump length preservation was achieved in all cases. Conclusions: Optimal postoperative treatment with physiotherapy and orthopaedic shoe support is important. If all these factors are present and if the patient is highly motivated a reintegration into normal life can be achieved.
- 1 July 2001
- Published by Hogrefe Publishing Group in Vasa
- Vol. 30 (3) , 206-211
Management therapierefraktärer hypovaskularisierter Wunden durch freie Muskelverpflanzung
Background: Chronic ulceration as a complication of arteriosclerotic disease, venous congestion or diabetes mellitus is still a serious clinical problem, resulting in immobilization, extended hospitalization and cost-intensive treatment. Other than standard conservative treatment protocols or early amputation, microsurgical free transfer of well vascularized muscle tissue onto chronic wounds can induce angiogenesis and improve wound healing even in the hypovascularized wound. Patients: From 1993–1999 we treated 12 patients (mean age: 46 years) with vascular ulcers of the lower extremity with free muscle or fasciocutaneous tissue transfer. Results: The average hospitalization was 51.4 days. The perioperative mortality was zero. In one patient with factor V deficiency a partial flap necrosis occurred. Two revisions of the micro anastomoses had to be performed. Two seromas occurred at the donor site. No secondary flap loss was observed. Extremity or stump length preservation was achieved in all cases. Conclusions: Optimal postoperative treatment with physiotherapy and orthopaedic shoe support is important. If all these factors are present and if the patient is highly motivated a reintegration into normal life can be achieved.
- 1 March 2001
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 25 (2) , 85-88
Effect of Ultrasonic Assisted Lipectomy (UAL) on Breast Tissue: Histological Findings
- 1 March 2001
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 25 (2) , 85-88
Effect of Ultrasonic Assisted Lipectomy (UAL) on Breast Tissue: Histological Findings
- 1 January 2000
- p. 74-8
[Gene therapy perspectives in modulation of wound healing].
A variety of reasons can afflict wound healing. Current research is focussed on the acceleration of wound healing by stimulating molecular processes. Gene therapy may offer completely new ways to treat chronic wounds. Possible advantages of gene therapeutic modulation of wound healing might be a long term efficiency, systemic or local regulation of gene expression and low side-effects. Current goals comprise the improvement of transfection efficiency and specificity. In vivo applications are therefore focussed on optimized inducible or even cell-type specific promotors, as well as on improved local application techniques. Studies from our laboratory demonstrate the possibility to combine modern cell culture techniques with different types of gene transfer. This enables the simultaneous grafting of manipulated cells to the wound with the continuous delivery of specific proteins of interest. Experimentally, this lead to accelerated closure of partial and full thickness animal wounds. Clinically, gene therapy for the treatment of chronic wounds seems to be a realistic goal within the next years and might be applicable for a variety of novel indications.
- 1 January 2000
- p. 74-8
[Gene therapy perspectives in modulation of wound healing].
A variety of reasons can afflict wound healing. Current research is focussed on the acceleration of wound healing by stimulating molecular processes. Gene therapy may offer completely new ways to treat chronic wounds. Possible advantages of gene therapeutic modulation of wound healing might be a long term efficiency, systemic or local regulation of gene expression and low side-effects. Current goals comprise the improvement of transfection efficiency and specificity. In vivo applications are therefore focussed on optimized inducible or even cell-type specific promotors, as well as on improved local application techniques. Studies from our laboratory demonstrate the possibility to combine modern cell culture techniques with different types of gene transfer. This enables the simultaneous grafting of manipulated cells to the wound with the continuous delivery of specific proteins of interest. Experimentally, this lead to accelerated closure of partial and full thickness animal wounds. Clinically, gene therapy for the treatment of chronic wounds seems to be a realistic goal within the next years and might be applicable for a variety of novel indications.
- 1 January 1999
- p. 40-4
[Free microsurgical flap-plasty in reconstructive therapy of diabetic foot ulcer].
The diabetic foot ulcer is a significant clinical problem often resulting in frustranous conservative treatment or early amputation. In certain cases transfer of well vascularized tissue can improve wound healing and lead to a length-spearing therapy. In this study the concept of microsurgical tissue transfer in the treatment of diabetic foot ulcers is introduced. Following a radical debridement and, if necessary a atypical length-spearing amputation the wound is covered by a free transplanted muscle flap followed by a split-thickness skin graft. In six patients treated with this procedure the extremity could be saved. The perioperative mortality was 0%, average hospitalization was 47.6 days. One flap was lost, two vascular revision were necessary. Several necrectomies and skin grafts were performed and one donor side seroma was drained. One hernia was observed after free rectus abdominus transfer. Compared to conservative treatment or amputation this concept leads to a length-spearing therapy and can increase success rates of rehabilitation and quality of life.
- 1 January 1999
- p. 40-4
[Free microsurgical flap-plasty in reconstructive therapy of diabetic foot ulcer].
The diabetic foot ulcer is a significant clinical problem often resulting in frustranous conservative treatment or early amputation. In certain cases transfer of well vascularized tissue can improve wound healing and lead to a length-spearing therapy. In this study the concept of microsurgical tissue transfer in the treatment of diabetic foot ulcers is introduced. Following a radical debridement and, if necessary a atypical length-spearing amputation the wound is covered by a free transplanted muscle flap followed by a split-thickness skin graft. In six patients treated with this procedure the extremity could be saved. The perioperative mortality was 0%, average hospitalization was 47.6 days. One flap was lost, two vascular revision were necessary. Several necrectomies and skin grafts were performed and one donor side seroma was drained. One hernia was observed after free rectus abdominus transfer. Compared to conservative treatment or amputation this concept leads to a length-spearing therapy and can increase success rates of rehabilitation and quality of life.
- 1 January 1999
- p. 81-6
[Keratinocyte transplantation and tissue engineering. New approaches in treatment of chronic wounds].
Cultured keratinocytes have been used for the treatment of extensive burns since disease lethality is reduced. Consequently, the treatment of chronic wounds with keratinocytes may be promising. Cell culture technology allows to expand keratinocytes up to 6000-fold in vitro after taking a single biopsy from patient. Today the transplantation of these in vitro cultured keratinocytes in different modifications is an established clinical treatment regimen for therapy of extensive wounds. For example, keratinocyte-fibrin-glue-suspensions, mainly consisting of proliferative epidermal basal cells, were used for the treatment of burns in experimental and clinical settings to bypass the disadvantages of conventional sheet grafts. Other approaches in tissue engineering for wound healing aim at the (epi-)dermal repair by the combination of allodermis and biomaterials, i.e. collagen-sponges and microspheres. Due to most recent efforts in keratinocyte culture techniques, developments in tissue engineering, research for novel biomaterials and gene therapy, therapy of chronic wounds may prove to be more efficient. Furthermore, from the socio-economical point of view, overall costs for treatment of chronic wounds could be reduced.
- 1 January 1999
- p. 81-6
[Keratinocyte transplantation and tissue engineering. New approaches in treatment of chronic wounds].
Cultured keratinocytes have been used for the treatment of extensive burns since disease lethality is reduced. Consequently, the treatment of chronic wounds with keratinocytes may be promising. Cell culture technology allows to expand keratinocytes up to 6000-fold in vitro after taking a single biopsy from patient. Today the transplantation of these in vitro cultured keratinocytes in different modifications is an established clinical treatment regimen for therapy of extensive wounds. For example, keratinocyte-fibrin-glue-suspensions, mainly consisting of proliferative epidermal basal cells, were used for the treatment of burns in experimental and clinical settings to bypass the disadvantages of conventional sheet grafts. Other approaches in tissue engineering for wound healing aim at the (epi-)dermal repair by the combination of allodermis and biomaterials, i.e. collagen-sponges and microspheres. Due to most recent efforts in keratinocyte culture techniques, developments in tissue engineering, research for novel biomaterials and gene therapy, therapy of chronic wounds may prove to be more efficient. Furthermore, from the socio-economical point of view, overall costs for treatment of chronic wounds could be reduced.
- 1 January 1999
- Published by Springer Nature
- p. 890-892
Angiogeneseinduktion nach Vakuumversiegelung — Klinische Erfahrungen und immunhistochemische Untersuchungen
- 1 January 1999
- Published by Springer Nature
- p. 890-892
Angiogeneseinduktion nach Vakuumversiegelung — Klinische Erfahrungen und immunhistochemische Untersuchungen
- 1 January 1998
- Vol. 115, 1186-8
[Surgically-induced angiogenesis as basic principle in treatment ov hypovascularized wounds--the nutritive flap].
Chronic wounds of the lower extremity as a result of diabetes, arteriosclerosis and microangiopathy are of significant clinical relevance, as they result in immobilization, extended hospitalization and cost-intensive treatment. Via transfer of well-vascularized tissue onto chronic wounds as a free transplanted muscle flap, if necessary connected to a venous bypass, angiogenesis is induced and wound healing improved. This concept leads to nonamputational therapy.
- 1 January 1998
- Vol. 115, 1186-8
[Surgically-induced angiogenesis as basic principle in treatment ov hypovascularized wounds--the nutritive flap].
Chronic wounds of the lower extremity as a result of diabetes, arteriosclerosis and microangiopathy are of significant clinical relevance, as they result in immobilization, extended hospitalization and cost-intensive treatment. Via transfer of well-vascularized tissue onto chronic wounds as a free transplanted muscle flap, if necessary connected to a venous bypass, angiogenesis is induced and wound healing improved. This concept leads to nonamputational therapy.
- 1 January 1998
- Vol. 115, 1194-6
[The free "emergency" rectus abdominis flap transfer for coverage of complex hand injuries].
Standard local flaps may be insufficient to cover extensive soft tissue defects of the upper extremity. To prevent further damage of exposed vital structures, early microsurgical free-flap transfer may be necessary. The rectus abdominis free muscle flap is introduced as a new and reliable procedure for emergency coverage of upper limb defects.
- 1 January 1998
- Vol. 115, 1194-6
[The free "emergency" rectus abdominis flap transfer for coverage of complex hand injuries].
Standard local flaps may be insufficient to cover extensive soft tissue defects of the upper extremity. To prevent further damage of exposed vital structures, early microsurgical free-flap transfer may be necessary. The rectus abdominis free muscle flap is introduced as a new and reliable procedure for emergency coverage of upper limb defects.